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Background: This study was conducted to determine the role of enteroaggregative Escherichia coli (EAEC) in
inflammatory diarrhea among hospitalized patients in Kolkata. The inflammatory pathogenesis of EAEC was
established in mice model and histopathological studies. Presence of fecal leucocytes (FLCs) can be suspected for
EAEC infection solely or as a mixed with other enteric pathogens.
Methods: Active surveillance was conducted for 2 years on 2 random days per week with every 5th patient
admitted to the Infectious Diseases Hospital (IDH). Diarrheal samples were processed by conventional culture,
microscopy, ELISA and molecular methods. Two EAEC isolated as sole pathogens were examined in mice after
induced intestinal infection. The intestinal tissue samples were processed to analyze the histological changes.
Results: Of the 2519 samples screened, fecal leucocytes, erythrocytes and occult blood were detected in 1629
samples. Most of the patients had acute watery diarrhea (75%) and vomiting (78%). Vibrio cholerae O1 was the main
pathogen in patients of 5–10 years age group (33%). Shigellosis was more in children from 2–5 years of age (19%),
whereas children <2 years appeared to be susceptible for infection caused by EAEC (16%). When tested for the
pathogenicity, the EAEC strains colonized well and caused inflammatory infection in the gut mucosa of BALB/C
mice.
Conclusion: This hospital-based surveillance revealed prevalence of large number of inflammatory diarrhea. EAEC
was the suspected pathogen and <2 years children appeared to be the most susceptible age group. BALB/C mice
may be a suitable animal model to study the EAEC-mediated pathogenesis.
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Gastroenteritis is a very common illness among children
living in tropical regions. At the global level, it was esti-
mated that about 1.87 million children aged less than
5 years die due to diarrhea [1]. Etiologically, a large number
of bacteria, viruses and parasites are responsible in causing
diarrheal illness. Among different pathogroups of diarrhea-
genic Escherichia coli (DEC), enteroaggregative E. coli
(EAEC) is gaining importance as it causes persistent and* Correspondence: dhira.saha@gmail.com
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reproduction in any medium, provided the oracute diarrhea both in developing and developed countries
[2,3]. In children, EAEC induced diarrhea is commonly as-
sociated with mucoid stool, which may sometimes contain
blood and fecal leucocytes (FLCs) [4,5]. In USA, EAEC is
the most common cause of diarrheal illness among all age
groups [6]. Despite lots of information available on the
virulence determinants of EAEC-mediated diarrhea, stud-
ies on the level of FLCs and associated histopathogenesis
in gut mucosa are very less [7,8]. From diarrheal disease
surveillance at the National Institute of Cholera and En-
teric Diseases (NICED), Kolkata, we conducted a prelimin-
ary study to understand the role of EAEC in inflammatory
diarrhea among hospitalized patients. We have identified
involvement of EAEC as a sole pathogen in most of thed. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the FLC was significantly associated with the presence of
EAEC along with the other pathogens (mixed infection).
We also studied the inflammatory changes induced by
EAEC in the mice model with two strains isolated as sole
pathogens from the diarrheal patients.
Results
Of the 2519 diarrheal stool specimens collected from
November 2007 to October 2009, FLCs, erythrocytes
and occult blood were detected in 1629 samples (65%).
FLC was mainly detected with acute watery diarrhea
(75%) and the rest (25%) of the patients had bloody
(4.3%), loose stool (20.1%) and mucoid (0.5%) stool. Fever
was recorded in 6% of the patients but the frequency ofTable 1 Age wise distribution of pathogens in FLC associated
Age <1 yr
(n=127)
1 to <5 yr
(n=134)
2 to <5 yr
(n=112)
5 to <10 yr
(n=73)
10
(
n (%) n (%) n (%) n (%)
Bacteria
Vibrio cholerae O1 14(11) 23(17.2) 28(25) 24(32.9)
Vibrio cholerae O139 0 0 0 1(1.4)
Vibrio cholerae Non
O1 Non O139
2(1.6) 0 0 4(5.5)
V. parahaemolyticus 1(0.8) 0 2(1.8) 41(5.5)
Vibrio fluvialis 3(2.4) 4(3) 1(0.9) 2(2.7)
Aeromonas spp. 0 1(0.7) 1(0.9) 1(1.4)
Campylobacter
jejuni
9(7.1) 18(13.4) 15(13.4) 4(5.5)
E. coli 1(0.8) 0 1(09) 0
Shigellae 6(4.7) 20(14.9) 21(18.8) 11(15.1)
Salmonella 0 1(0.7) 1(0.9) 1(1.4)
EPEC 8(6.3) 4(3) 2(1.8) 3(4.1)
ETEC Group 3(2.4) 11(8.2) 3(2.7) 0
EAEC 20(15.7) 21(15.7) 11(9.8) 3(4.1)
Virus
Rotavirus 64(50.4) 73(54.5) 28(25) 5(6.8)
Adenovirus 26(20.5) 18(13.4) 8(7.1) 3(4.1)
Norovirus G1 0 1(0.7) 0 0
Norovirus G2 4(3.1) 6(4.5) 4(3.6) 1(1.4)
Sapovirus 6(4.7) 2(1.5) 4(3.6) 0
Astrovirus 3(2.4) 6(4.5) 4(3.6) 2(2.7)
Parasite p
Blastocystis hominis 0 0 0 1(1.4)
Entamaeba
histolytica
3(2.4) 10(7.5) 5(4.5) 1(1.4)
Giardia lamblia 14(11) 22(16.4) 20(17.9) 18(24.7)
Cryptosporidium spp. 22(17.3) 16(11.9) 10(8.9) 4(5.5)vomiting was high (78%). Age group difference of diar-
rheal cases with various enteric pathogens and FLCs are
shown in (Table 1). Children <2 years seems susceptible to
EAEC (16%), whereas in all age groups the EAEC infec-
tion rate was less (7%). Overall, the infection rate of Vibrio
cholerae O1 and Shigella spp. were high in 5-10 years age
group compared to EAEC.
Diarrhea caused by a single pathogen with high FLC
was detected in 666 cases (41%) than mixed pathogens
511 cases (31%)- Figure 1. EAEC was isolated as a sole
pathogen in 23.9% of the cases and in 76.1% of the cases
EAEC was identified as a mixed pathogen with other en-
teric bacteria/virus/parasite. Interestingly, FLC was sig-
nificantly high when any of the E. coli pathogroups was
present as a mixed pathogen (p = >0.001). Generally,diarrheal patients at IDH, Kolkata
to <18 yr
n=126)
Age <18 yr
(n=1057)
All age Gr.,
(N=1629)
Ocult blood
with diarrhoeal
pathogens
Total samples
processed
(n=2519)
n (%) n (%) n (%) % n (%)
42(33.3) 239(22.6) 370(22.7) 56.6 654(26)
0 1(0.1) 2(0.1) 100 2(0.1)
1(0.8) 32(3) 39(2.4) 70.9 55(2.2)
4(3.2) 61(5.8) 72(4.4) 97.3 74(2.9)
2(1.6) 24(2.3) 36(2.2) 65.5 55(2.2)
0 13(1.2) 16(1) 64 25(1)
7(5.6) 34(3.2) 87(5.3) 73.7 118(4.7)
4(3.2) 13(1.2) 19(1.2) 86.4 22(0.9)
10(7.9) 73(6.9) 141(8.7) 91.6 154(6.1)
2(1.6) 14(1.3) 19(1.2) 82.6 23(0.9)
0 18(1.7) 35(2.1) 77.8 45(1.8)
6(4.8) 61(5.8) 84(5.2) 73.7 114(4.5)
8(6.3) 46(4.4) 109(6.7) 68.6 159(6.36)
10(7.9) 110(10.4) 290(17.8) 58.8 493(19.6)
3(2.4) 32(3) 90(5.5) 71.4 126(5)
0 3(0.3) 4(0.2) 66.7 6(0.2)
5(4) 16(1.5) 36(2.2) 50 72(2.9)
1(0.8) 13(1.2) 26(1.6) 63.4 41(1.6)
4(3.2) 24(2.3) 43(2.6) 72.9 59(2.3)
0 7(0.7) 8(0.5) 72.7 11(0.4)
5(4) 45(4.3) 69(4.2) 84.1 82(3.3)
25(19.8) 98(9.3) 197(12.1) 70.1 281(11.2)
4(3.2) 57(5.4) 113(6.9) 71.5 158(6.3)
Sole
666 (40.9%)
Mixed
511(31.4%)
Virus
142(8.7%)
Parasite
89(5.5%)
Bacteria
435(26.7%)
Bacteria with Parasite
178(34.8%)
Bacteria with Virus
176(34.4%)
Virus with Parasite
103(20.2%)
No pathogen
452 (27.7%)
Stool with fecal leucocytes
(n=1629)
Patient Enrolled with 
sample
(2519)
Patients Admission 
(45,004)
Figure 1 Flow diagram showing the description of sole and mixed pathogens detected among the acute diarrheal patients.
Figure 2 EAEC strain 00611 treated mice intestinal mucosa on
10th day showing disrupted surface epithelium (black arrow)
and exudates, grossly widened villous lamina propria with
inflammatory cellular infiltrates (red arrow) (Hematoxylin &
Eosin stain)-40x.
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enteric bacteria, which was 4 and 8 times high com-
pared to parasites and enteric viral infections, respect-
ively (Table 1).
In order to understand the pathogenesis of EAEC, two
serologically confirmed strains isolated as sole pathogen
from diarrheal patients were tested in the BALB/C mice.
On 10th day of inoculation with the EAEC strain 00611
(Serogroup O6), ileum showed disrupted surface epithe-
lium and exudates, grossly widened villous lamina propria
with inflammatory cellular infiltrates basically consisting
of mononuclear cells and neutrophils (Figure 2). Dilated
villi with scattered hemorrhage and inflammatory cells
were also observed with the other EAEC strain 3544 (ser-
ogroup O6) (Figure 3). After the 2nd inoculation (10th day
from the 1st dose), 4 animals from test and control groups
were sacrificed on 11th day. Histopathological study re-
vealed gross alteration of villous architecture, damaged
surface epithelium, oedematous and congested lamina
propria and submucosa with inflammatory cells with both
the EAEC strains. The hisopathological changes after 2nd
inoculation appeared more severe with both the strains
(Figures 4 and 5). Bacterial shedding/gram of stool were
maximum on 11th day after 2nd inoculation (Figure 6).
After 1st and 2nd dose of infection, 3rd set of sacrifice was
made on 20th day. Histomorphology of ileal tissue with
each two strain showed almost normal appearance this
time similar to that of control (Figure 7 and Figure 8).
Discussion
Diarrhea and infectious enterocolitis is a major health prob-
lem especially among children in developing countries,
Figure 3 EAEC strain 3544 treated mice intestinal mucosa on
10th day showing dilated villi with scattered hemorrhage (black
arrow) and inflammatory cells (red arrow) (Hematoxylin &
Eosin stain)-40x.
Figure 4 Mice intestine on 11th day after 2nd challenge of
00611 strain showing grossly altered villous architecture,
ruptured surface epithelium (black arrow), oedematous &
congested lamina propria and submucosa (yellow arrow) with
inflammatory cells (Hematoxylin & Eosin stain)-40x.
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context, our two year surveillance study revealed inflamma-
tory diarrhea in 65% of the cases, which is quite high. Since
more than 20,000 acute diarrheal cases are getting admitted
in the IDH per year, an active surveillance was made in
which stool specimens were collected from every 5th hospi-
talized patient with diarrhea or dysentery on two randomly
selected days in a week.
FLCs in the diarrheal stool smear are suggestive of in-
vasive etiology [10,11] and based on this estimation and
fecal lactoferrin, inflammatory diarrhea can be deter-
mined. A wide range of pathogens in different age groups
were identified in this study. Etiologically, bacterial diar-
rhea was the most predominant one. Children in the age
group of 5 to >10 years seems more susceptible to V. cho-
lerae infection (33%), whereas the age group up to 5 years
were susceptible to shigellosis (19%). The younger age
group children <2 years were susceptible to EAEC infec-
tion (16%).
Other than bacteria, viruses and parasites were also
identified either as sole or in mixed pathogens. EAEC
was identified with other enteric pathogens, which was
statistically significant (p=>0.001). The duration of diar-
rhea among EAEC infected patients was long comparedto other pathogens (data not shown). In many investiga-
tions, EAEC was found to be associated with persistent
diarrhea [12,13].
In clinical settings, it must be challenging to distin-
guish inflammatory and non-inflammatory diarrhea. The
results of our surveillance showed that acute watery
diarrhea as the major clinical symptom in which 75% of
the cases had FLCs and lactoferrin. This data indicates
that inflammatory diarrhea is more in this region. In
many investigations, the clinical presentation of EAEC
infection was mostly associated with acute watery diar-
rhea especially among infants and young children with
occasional presence of blood and mucus [14,15]. Consid-
ering identification of large number of acute diarrheal
cases with the high FLCs, there is a need to correct de-
hydration in patients and reduce the infection of EAEC.
This collective therapy may reduce the duration of stay
in the hospital. Similar to our observation, other studies
have also reported about the presence of FLCs with mild
inflammation in DEC infected cases [16-19] especially
by EAEC [20,21].
Disease manifestation and subsequent inflammatory
changes were tested in mice model with human isolates
Figure 5 Mice intestine on 11th day after 2nd challenge of 3544
strain showing damaged villous structure with widely dilated &
congested lamina propria and submucosa (yellow arrow) and
scattered inflammatory cells (green arrow) (Hematoxylin &
Eosin stain)-40x.
Figure 6 Day wise CFU count of bacterial shedding per gram of EAEC
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the EAEC strains and subsequent bacterial shedding in
the stools revealed prolonged colonization and signifi-
cant inflammatory changes in intestinal tissue [22-24].
Histological sections of ileal tissue revealed damaged
surface mucosa with inflammatory infiltrates in lamina
propria spreading to the muscularis mucosa and sub-
mucosa. Maximum fecal shedding of the organism was
noted after 2nd oral inoculation on 11th day and histo-
pathological changes confirmed this observation.
Frank blood and pus in the stools were not observed
in mice challenged with EAEC though loose stool with
mucus was occasionally seen. Fecal shedding of the or-
ganisms and histological changes support mild inflam-
mation in the mice infection studies. After 20 days from
the 2nd inoculation, no inflammation was noticed in mice.
This indicates the normal recovery of animals in due
course of time. However, this result cannot be correlated
with human infection mediated by EAEC as the severity
of infection is more pronounced. Experimental evidence
showed that there may be an inhibition of water absorp-
tion due to damage of gut surface epithelium caused by
enteric bacteria or its toxins [25]. Considering this aspect,
the treatment of inflammatory diarrheal patients with oral
rehydration solution may be less effective.
Most of the rural hospitals in India and other develop-
ing countries are not equipped with modern laboratory
facilities for the early identification of pathogens from
clinical specimens. In such settings, direct-microscopy willinfected mice stool.
Figure 7 Mice intestine almost coming back to normal on 20th
day after 1st & 2nd challenge of EAEC strain 00611-40x.
Figure 8 Mice intestine treated with PBS on 10th day as control
(Hematoxylin & Eosin stain)-40x.
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may help the physicians to take prompt decision regard-
ing management of acute diarrhea while expecting the
diagnostic results. Screening of FLC is simple, rapid and
cost effective and that can be done in outpatient depart-
ment. ELISA and PCR techniques may give rapid results
which are highly specific and sensitive but the conven-
tional microscopy may act as a supportive tool for the
simple diagnosis.
Our data suggest i) high FLC is frequently associated
with bacterial diarrheas, ii) fecal leucocytes is 4 times
higher in bacterial diarrhea than parasitic diarrhea and 8
times higher than viral diarrhea, iii) in the case of mixed
infection, diarrheagenic E. coli may be the other suspected
pathogen, iv) bacterial invasion in intestinal mucosa is a
multistep process and in this regard, BALB/C mice could
be an useful model to study the EAEC infection.
Conclusions
This hospital based surveillance revealed high incidence
of inflammatory diarrhea in Kolkata. Among the inflam-
matory diarrheal cases, the role of EAEC along with
other pathogen(s) was found to be significant. This asso-
ciation was more pronounced in children >2 years of
age. Histopathological studies with EAEC have showntypical inflammation in the gut microvilli. The BALB/C
mice could be considered as an effective model for fur-
ther study of EAEC pathogenesis.
Methods
Collection and analysis of stool specimens
From November 2007 to October 2009, a systematic ac-
tive surveillance was conducted at the NICED to detect
the prevalence of different enteric pathogens among acute
diarrheal patients admitted at the IDH. Stool specimens
were collected from all age groups from every 5th hospi-
talized patient with diarrhea or dysentery on two ran-
domly selected days (48 hrs) in a week. Two thousand five
hundred nineteen stool specimens were collected in ster-
ile containers and sent to the laboratory within 2 hrs. For
the detection of enteric pathogens, conventional culture
methods, immunologic and molecular microbiologic tech-
niques were employed in the study [26].
Fecal leucocytes and RBC in stool
As a marker of inflammation, FLC and red blood cells
(RBC) were examined microscopically (Olympus CX41,
Olympus Corporation, Tokyo, Japan) by smearing a thin
layer of fresh stool on a glass slide after stained with
methylene blue [27]. Stool specimen with FLCs >10
Saha et al. Gut Pathogens 2013, 5:36 Page 7 of 8
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under high power was considered positive.
Fecal lactoferrin
The specimens positive for FLCs were further tested to
determine the presence of fecal lactoferrin using an
immunochromatographic detection kit (Leukoez value;
Tech Lab, VA).
Analysis of fecal occult blood (FOBT)
Microscopic presence of RBC was further confirmed
by Hemaoccult 11 (Smithkline Diagnostics, San Jose,
CA) [28,29].
Selection of bacterial strain
Two EAEC strains 00611 and 3544, isolated as sole
pathogens from diarrheal patients and belonging to
serogroups O6 and O6, respectively were selected for
further study along with a non-pathogenic E. coli strain
DH5α. The EAEC strains were chloramphenicol resistant
and grown in tryptic soy agar (TSA, Dfico, BD, Sparks,
MD) spread plate method in four different concentrations
of the antibiotic i.e., 25 μg/ml, 50 μg/ml, 75 μg/ml and
100 μg/ml. The EAEC strains were resistant to all the
concentrations of chloramphenicol but the control strain
(DH5α) remained susceptible for this antibiotic.
Animal studies
The animal model study in this report was approved by
the Institutional animal Ethical Committee (Apro/77/24/
11/2010,Reg.No.NICED/CPCSEA(AW)215/2009-2015).
Six weeks old male BALB/C mice were used in the
study and were provided with sterilized water and food
before and during the experiment. All the animals were
kept in the germ-free environment. Twenty mice were
inoculated intragastrically with two EAEC strains (ten in
each group) (0.2 ml) by using a 1 ml tuberculin syringe fit-
ted with a 20 gauge needle. The mice were closely ob-
served to ensure that they did not regurgitate or aspirate
the given inoculum. Ten mice were inoculated separately
with 5% (w/v) filter sterilized phosphate buffered saline
(0.2 ml) and used as control. Mice were closely monitored
and stool samples were collected daily for bacteriological
analysis. On 10th day, 4 mice each from the test and con-
trol groups were sacrificed. The rest 12 mice in two test
groups were reinoculated with the same dose of each of
the EAEC strain and maintained under the same condition
as mentioned before. On 11th day after 2nd inoculation, 2
mice from test group and 2 from control group were sacri-
ficed. Mice feces were screened for the presence of the test
strains over a period of 20 days and the last sacrifice of 4
test mice and 4 control mice was made on 20th day of the
experiment. After each batch of the experiment, intestinal
tissue samples were preserved for histopathology. Forspecific enumeration and identification of EAEC, samples
of freshly passed feces were homogenized in sterile
phosphate-buffered saline (PBS), spread on TSA contain-
ing 75 μg of chloramphenicol, and incubated overnight
at 37°C. The identity of the colonies resembling E. coli
was confirmed by typical morphology and agglutination
with the respective O serogroup rabbit antisera (Denka
Seiken, Tokyo, Japan). The experiment was repeated
two times and average of the test and control groups
were recorded.
Histology
Samples from mice intestine were fixed in 10% buffered
formalin (pH 7.4), dehydrated and embedded in paraffin.
Serial thin sections (3-5 μm) were made by Rotary micro-
tome (Leica 2145, Germany) and stained with hematoxylin
and eosin stain to observe the pathomorphological changes.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DRS conceived of the study and wrote the manuscript, TR, SS and HK
designed the research SG and DN performed the research RK, statistically
analysed the data. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by funds from the Ministry of Education, Culture,
Sports, Science and technology of Japan and from intramural grants of the
Indian Council of Medical Research, New Delhi.
Author details
1Division of Histology & Electron microscopy, National Institute of Cholera
and Enteric Diseases, P-33, C.I.T Road, Scheme XM, Beliaghata, Kolkata
700 010, West Bengal, India. 2Division of Bacteriology, National Institute of
Cholera and Enteric Diseases, P-33, C.I.T Road, Beliaghata, Kolkata 700 010,
West Bengal, India. 3Division of Data Management, National Institute of
Cholera and Enteric Diseases, P-33, C.I.T Road, Beliaghata, Kolkata 700 010,
West Bengal, India. 4Collaborative Research Center of Okayama University for
Infectious Diseases in India, P-33, C.I.T Road, Beliaghata, Kolkata 700 010, West
Bengal, India.
Received: 30 August 2013 Accepted: 27 October 2013
Published: 3 December 2013
References
1. Boschi-Pinto C, Velebit L, Shibuya K: Estimating child mortality due to
diarrhoea in developing countries. WHO 2008, 86:710–717.
2. Huang DB, Okhuysen PC, Jiang ZD, Dupont HL: Enteroaggregative
Escherichia coli: an emerging enteric pathogen. Am J Gastroenterol 2004,
99:383–389.
3. Okeke IN, Nataro JP: Enteroaggregative Escherichia coli. Lancet 2001,
1:304–313.
4. Huang DB, DuPont HL: Enteroaggregative Escherichia coli an emerging
pathogen in children. Semin Pediatr Infect Dis 2004, 15:266–271.
5. Jiang ZD, Okhuysen PC, Guo DC, He R, King TM, Dupont HL: Genetic
susceptibility to Enteroaggregative Escherichia coli Diarrhea: polymorphism
in the interleukin-8 promoter region. J Infect Dis 2003, 188:506–511.
6. Nataro JP, Mai V, Johnson J, Blackwelder WC, Heimer R, Tirrell S, Edberg SC,
Braden CR, Morris G Jr, Hirshon JM: Diarrheagenic Escherichia coli infection
in Baltimore, Maryland and New Haven Connecticut. Clin Infect Dis 2006,
43:402–407.
7. Nataro JP, Kaper JB: Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998,
11:142–201.
Saha et al. Gut Pathogens 2013, 5:36 Page 8 of 8
http://www.gutpathogens.com/content/5/1/368. Zamboni A, Fabbricotti SH, Fagundes-Neto U, Scaletsky ICA: Enteroaggregative
Escherichia coli virulence factors are found to be associated with infantile
diarrhea in Brazil. J Clin Microbiol 2004, 42:1058–1063.
9. Guerrant RL, Shields DS, Thorson SM, Schorling JB, Groschel DHM:
Evaluation and diagnosis of acute infectious diarrhea. Am J Med 1985,
78:91–98.
10. Radetsky M: Laboratory evaluation of acute diarrhoea. Pediatr Infect Dis
1986, 5:230–238.
11. Alvarado T: Fecal leucocytes in patients with infectious diarrhea. Trans R
Soc Trop Med Hyg 1983, 77:316–320.
12. Fang G, Lima AAM, Martins CV, Nataro JP, Guerrant RL: Etiology and
epidemiology of persistent diarrhea in Northeastern Brazil: a hospital
based, prospective, case-control study. J Pediatr Gastroenterol Nutr 1995,
21:137–144.
13. Lima AAM, Moore SR, Barboza MS Jr, Soares AM, Schleupner MA, Newman
RD, Sears CL, Nataro JP, Fedorko DP, Wuhib T, Schorling JB, Guerrant RL:
Persistent diarrhea signals a critical period of increased diarrhea burdens
and nutritional short falls: a prospective cohort study among children in
Northeastern Brazil. J Infect Dis 2000, 181:1643–1651.
14. Huang DB, Nataro JP, DuPont HL, Kamat PP, Mhatre AD, Okhuysen PC,
Chiang T: Enteroaggregative Escherichia coli is a cause of acute diarrheal
illness: a mata-analysis. Clin Infect Dis 2006, 43:556–563.
15. Shazberg G, Wolk M, Schmidt H, Sechter I, Gottesman G, Miron D:
Enteroaggregative Escherichia coli serotype O126:H27, Israel. Emerg Infect
Dis 2003, 9:1170–1173.
16. Cennimo D, Abbas A, Huang DB, Chiang T: The prevalence and virulence
characteristics of enteroaggregative Escherichia coli at an urgent care
clinic in the USA: a case control study. J Med Microbiol 2009, 58:403–407.
17. Huang DB, DuPont HL, Jiang ZD, Carlin L, Okhuysen PC: Interleukin-8
response in an intestinal HCT-8 cell line infected with enteroaggregative
and enterotoxigenic Escherichia coli. Clin Diagn Lab Immunol 2004,
11:548–551.
18. Jindal N, Arora S: Role of fecal leucocytes in the diagnostic evaluation of
acute diarrhea. Indian J Med Sci 1991, 45:261–264.
19. McNeely WS, DuPont HL, Mathewson JJ, Oberhelmn RA, Ericsson CD: Occult
blood versus fecal leucocytes in the diagnosis of bacterial diarrhea, a
study of U.S. travelers to Mexico and Mexican children. Am J Trop Med
Hyg 1996, 55:430–433.
20. Steiner TS, Lima AAM, Nataro JP, Guerrant RL: Enteroaggregative
Escherichia coli produce intestinal inflammation and growth impairment
and cause Interleukin-8 release from intestinal epithelial cells. J Infect Dis
1998, 177:88–96.
21. Greenberg DE, Jiang Z, Steffen R, Verneker MP, DuPont HL: Markers of
inflammation in bacterial diarrhea among travelers with a focus on
enteroaggregative Escherichia coli pathogenicity. J Infect Dis 2002,
185:944–949.
22. Roche JK, Cabel A, Sevilleja J, Nataro J, Guerrant RL: Enteroaggregative
Escherichia coli (EAEC) impairs growth while malnutrition worsens EAEC
infection: a novel murine model of the infection malnutrition cycle.
J Infect Dis 2010, 202:506–514.
23. Vial PA, Robins-Browne R, Lior H, Prado V, Kaper JB, Nataro JP, Maneval D,
Elsayed A, Levine MM: Characterization of enteroadherent-aggregative
Escherichia coli, a putative agent of diarrheal disease. J Infect Dis 1998,
158:70–79.
24. Hicks S, Candy DC, Phillips AD: Adhesion of enteroaggregative Escherichia
coli to pediatric intestinal mucosa in vitro. Infect Immun 1996, 64:4751–4760.
25. Gerhardt E, Masso M, Paton AW, Paton JC, Zotta E, Ibarra C: Inhibition of
water absorption and selective damage to human colonic mucosa are
induced by subtilase cytotoxin produced by Escherichia coli O113:H21.
Infect Immun 2013, 81:2931–2937.
26. Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng B, Oundo
J, Ramamurthy T, Tamboura B, Zaidi AK, et al: Diagnostic microbiologic
methods. Clin Infect Dis 2012, 55(S4):S294–S302.27. Peirce JE, DuPont HL, Lewis KR: Acute diarrhea in a residential institution
for the retarded. Usefulness of fecal leucocyte examination. Am J Dis
Child 1974, 128:772–775.
28. Grasnick A: Processing and interpretation of fecal cultures. In Clinical
microbiology procedures handbook. Vol 1. Edited by Isenberg HD.
Washington DC: American society for Microbiology; 1992:1.10. 1-1.
29. Silletti RP, Lee G, Ailey E: Role of stool screening tests in diagnosis of
inflammatory bacterial enteritis and in selection of specimens likely to
yield invasive enteric pathogens. J Clin Microbiol 1996, 34:1161–1165.
doi:10.1186/1757-4749-5-36
Cite this article as: Saha et al.: Inflammatory diarrhea due to
enteroaggregative Escherichia coli: evidence from clinical and mice
model studies. Gut Pathogens 2013 5:36.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
